Advertisement
Research Article

WR279,396, a Third Generation Aminoglycoside Ointment for the Treatment of Leishmania major Cutaneous Leishmaniasis: A Phase 2, Randomized, Double Blind, Placebo Controlled Study

  • Afif Ben Salah equal contributor,

    equal contributor Contributed equally to this work with: Afif Ben Salah, Pierre A. Buffet

    Affiliation: Institut Pasteur de Tunis, Tunis, Tunisia

    X
  • Pierre A. Buffet equal contributor,

    equal contributor Contributed equally to this work with: Afif Ben Salah, Pierre A. Buffet

    Affiliation: Institut Pasteur, Paris, France

    X
  • Gloria Morizot,

    Affiliation: Institut Pasteur, Paris, France

    X
  • Nathalie Ben Massoud,

    Affiliation: Institut Pasteur de Tunis, Tunis, Tunisia

    X
  • Amor Zâatour,

    Affiliation: Institut Pasteur de Tunis, Tunis, Tunisia

    X
  • Nissaf Ben Alaya,

    Affiliation: Institut Pasteur de Tunis, Tunis, Tunisia

    X
  • Nabil Bel Haj Hamida,

    Affiliation: Institut Pasteur de Tunis, Tunis, Tunisia

    X
  • Zaher El Ahmadi,

    Affiliation: Direction Régionale de la Santé de Sidi Bouzid, Sidi Bouzid, Tunisia

    X
  • Matthew T. Downs,

    Affiliation: Statistics Collaborative, Washington, D.C., United States of America

    X
  • Philip L. Smith,

    Affiliation: United States Army Medical Materiel Development Activity, Fort Detrick, Maryland, United States of America

    X
  • Koussay Dellagi,

    Affiliation: Institut Pasteur de Tunis, Tunis, Tunisia

    X
  • Max Grögl mail

    max.grogl1@us.army.mil

    Affiliation: Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

    X
  • Published: May 05, 2009
  • DOI: 10.1371/journal.pntd.0000432

Reader Comments (0)

Post a new comment on this article